Skip to main content
Sign In
 

Cecilia C. Low Wang, M.D.

Associate Professor of Medicine


​​Dr. Low Wang joined the faculty of the University of Colorado Denver School of Medicine after completing her fellowship in Endocrinology, Diabetes and Metabolism at the University of Colorado. She graduated from Pomona College with a B.A. in Chemistry, earned her medical degree from the University of Rochester School of Medicine and Dentistry, and completed her residency training in Internal Medicine at the University of Utah Health Sciences Center, where she served as Chief Medical Resident. She is board-certified in Endocrinology, Metabolism, and Diabetes. She directs the inpatient Glucose Management Team at the University of Colorado Hospital, sees outpatients in the University of Colorado Endocrine Practice, and attends on both the inpatient Endocrine consult service at the University of Colorado Hospital and the VA Medical Center, and the inpatient medical service at the University of Colorado Hospital.  She is the Associate Director for the Fellowship and Education in the Endocrinology Division. In addition, she is actively involved with the Clinical Trialists Group at CPC Clinical Research. Dr. Low Wang currently conducts clinical research in diabetes and metabolism. Her prior research was focused on vascular smooth muscle cell biology, specifically vascular wall insulin signaling, in a cell culture model of selective insulin resistance and a porcine model of obesity and the metabolic syndrome. Her clinical interests include: inpatient hyperglycemia, complications of diabetes (particularly cardiovascular disease), insulin resistance, obesity and weight management, vitamin D deficiency/insufficiency, and general endocrinology. Dr. Low Wang recently completed the Teaching Scholars Program through the Academy of Medical Educators.        
​​

  • Diabetes
  • Cardiovascular disease
  • Inpatient hyperglycemia
  • Obesity

Selected Publications

 

  1. Reusch JEB, Wang CC. Cardiovascular disease in diabetes: Where does glucose fit in? J Clin Endocrinol Metab 2011;96:2367-2376. PMID: 21593112.

  2. Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, Wang C, Kam I, Draznin B. Subcutaneous Administration of Glargine to Diabetic Patients Receiving Insulin Infusion Prevents Rebound Hyperglycemia. Journal of Clinical Endocrinol Metab 2012;97(9):3132-3137. PMID 22685233.

  3. Wang CC, Reusch JEB. Cardio-Diabetes: Special Considerations for Patients with Diabetes and Cardiovascular Disease. Diabetes and Cardiovascular Disease: Changing the Focus from Glycemic Control to Improving Long Term Survival. Am J Cardiol 2012;110(9 Suppl):58B-68B. PMID: 23062569.

  4. Wang CC, Adochio R, Leitner JW, Abeyta I, Draznin B, Cornier MA. Effects of a high fat, low carbohydrate versus a low fat, high carbohydrate hypocaloric diet on skeletal muscle insulin signalling in obese individuals. Metabolism 2013;62(4):595-603. PMID: 23174405.

  5. Low Wang CC, Xu Y, Lu L, Leitner JW, Gunter J, Sarraf M, Draznin B, Greyson CR, Reusch JEB, Schwartz GG. Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome. Journal of Diabetes and Its Complications 2013. http://dx.doi.org/10.1016/j.jdiacomp.2013.02.009. PMID: 23558108.

  6. Draznin B, Gilden J, Golden SH, and Inzucchi SE for the PRIDE investigators: Baldwin D, Bode BW, Boord JB, Braithwaite SS, Cagliero E, Draznin B, Dungan KM, Falciglia M, Figaro MK, Gilden J, Golden SH, Hirsch IB, Klonoff D, Korytkowski MT, Kosiborod M, Lien LF, Magee MF, Masharani U, Maynard G, McDonnell ME, Moghissi ES, Rasouli N, Rubin DJ, Rushakoff RJ, Sadhu AR, Schwartz S, Seley JJ, Umpierrez GE, Vigersky RA, Low CC, Wexler DJ. Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action. Diabetes Care 2013;36:1807-1814. PMID:23801791.

  7. Draznin B, Wang Y, Seggelke S, Hawkins RM, Gibbs J, Bridenstine M, Rasouli N, Wang CL. Glycemic control and outcomes of hospitalization in noncritically ill patients with type 2 diabetes admitted with cardiac problems or infections. Endocr Pract 2014;20(12):1303-1308. doi: 10.4158/EP14174.OR. PMID: 25100383

  8. Low Wang CC, Galinkin JL, Hiatt WR. Toxicity of a novel therapeutic agent targeting mitochondrial complex I. Clin Pharmacol Ther 2015 Jun 25. doi: 10.1002/cpt.178. [Epub ahead of print]
​​
  • Diabetes Mellitus
  • Insulin Resistance
  • Obesity and weight management
  • Pre-diabetes
  • Vitamin D Deficiency
  • Thyroid dysfunction​

Medical Schools
MD, University of Rochester School of Medicine and Dentistry (1996)

Undergraduate Schools
BA, Pomona College (1991)

Internships
University of Utah Medical Center Program (1997)

Residency Program
University of Utah Medical Center Program, Chief Resident, Internal Medicine (1999)

Fellowships
University of Colorado, Internal Medicine - Endocrinology, Diabetes, and Metabolism (2003)

​​